Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fox

Showing results (131-140 of 2,777) with videos related to

Pageof 278
Sort By:
Neurology|March 5, 2010
Primary neuroprotection: the Holy Grail of multiple sclerosis therapyRobert J Fox
Social Science & Medicine (1982)|September 1, 1997
Space, sterility and surgery: circuits of hygiene in the operating theatreN J Fox
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|April 1, 1994
Transient global amnesiaA J Fox
Time|June 1, 2007
Time 100 scientists & thinkers. Douglas MeltonMichael J Fox
The American Journal of Managed Care|September 30, 2010
Emerging oral agents for multiple sclerosisEdward J Fox
Applied Optics|May 11, 2010
Thermal design for germanium acoustooptic modulatorsA J Fox
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 11, 2013
In the coming year we should abandon interferons and glatiramer acetate as first-line therapy for MS: yesRobert J Fox
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2016
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - NORobert J Fox
Wilhelm Roux' Archiv Fur Entwicklungsmechanik Der Organismen|March 18, 2017
Contribution of cytoplasmic enzymes to apparent heterogeneity of rat brain mitochondriaDavid J Fox
AORN Journal|March 1, 1993
Preventing glove tears, sharp injuriesV J Fox
Pageof 278

Showing results (131-140 of 2,777) with videos related to

Sort By:
Pageof 278
Neurology|March 5, 2010
Primary neuroprotection: the Holy Grail of multiple sclerosis therapyRobert J Fox
Social Science & Medicine (1982)|September 1, 1997
Space, sterility and surgery: circuits of hygiene in the operating theatreN J Fox
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|April 1, 1994
Transient global amnesiaA J Fox
Time|June 1, 2007
Time 100 scientists & thinkers. Douglas MeltonMichael J Fox
The American Journal of Managed Care|September 30, 2010
Emerging oral agents for multiple sclerosisEdward J Fox
Applied Optics|May 11, 2010
Thermal design for germanium acoustooptic modulatorsA J Fox
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 11, 2013
In the coming year we should abandon interferons and glatiramer acetate as first-line therapy for MS: yesRobert J Fox
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2016
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - NORobert J Fox
Wilhelm Roux' Archiv Fur Entwicklungsmechanik Der Organismen|March 18, 2017
Contribution of cytoplasmic enzymes to apparent heterogeneity of rat brain mitochondriaDavid J Fox
AORN Journal|March 1, 1993
Preventing glove tears, sharp injuriesV J Fox
Pageof 278